Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Prostate-specific membrane antigen DNA vaccine safe in renal cell carcinoma patients

Feb. 26, 2008

Novel 5-HT6 receptor antagonist potentially useful as cognition enhancer

Feb. 25, 2008

Positive preclinical results with staphylococcal enterotoxin B vaccine (STEBVax)

Feb. 25, 2008

Association between GVAX-induced immune responses and survival in patients with prostate cancer

Feb. 22, 2008

Antiangiogenic gene therapy potentially useful for metastatic renal cell carcinoma

Feb. 22, 2008

No viral resistance to R-7128 seen in HCV genotype 1 patients

Feb. 22, 2008

Abiraterone active in phase I and II studies in castration-resistant prostate cancer

Feb. 21, 2008

Mixed results seen with PI-88-docetaxel in hormone-refractory prostate cancer

Feb. 21, 2008

Data on UK-453061 in vitro activity, safety and potential for interactions reported

Feb. 21, 2008

Phase I study finds picoplatin plus docetaxel safe in hormone-refractory prostate cancer

Feb. 21, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026